Menu UNITED KINGDOM UK About Teva Explore Teva in the UK Explore Teva in the UK Our mission is to be a global leader in generics and biopharmaceuticals, improving the lives of patients across the world Teva is a big player on the world stage - that brings considerable benefits to patients in the UK 01 You might be surprised to learn that we've been supplying medicines for over 80 years in the UK. We were established in Yorkshire back in the 1930s – which means we’ve been around longer than the NHS! Enabling access to high quality medicines and treatment options 1,800 medicines 40,000 employees 200,000,000 patients At Teva we believe that everyone should have access to high quality medicine that helps manage disease, fights infection, or simply improves overall health We develop, produce and market affordable generic medicines, as well as innovative and specialty pharmaceuticals and biologics, and over-the-counter consumer healthcare products. That’s along with supplying active pharmaceutical ingredients to nearly 1,000 customers in over 100 countries. Our diverse family of over 40,000 employees is the beating heart of our company, working together to find innovative and creative solutions to the healthcare challenges of today and tomorrow. As the global leader in generic medicines, nearly 200 million patients across six continents take one of our products every day. 01 02 Concentrating our efforts on core therapeutic areas We focus on developing, personalising and improving treatment of disorders of the central nervous system, migraine, respiratory conditions, oncology and pain management. Our medicines improve the lives of patients in so many ways - that could be by fighting infections and controlling cholesterol, or it could be through offering flexible treatment options for migraine, relieving the symptoms of asthma, or providing lifesaving injectable medicines and pain relief for cancer sufferers. We’re also the company behind well-known brands in the consumer health and baby care sector, such as Sudocrem® and Infacol®. Central Nervous System Movement disorders and neurodegeneration Migraine Respiratory Oncology & Pain We play an important role in delivering value to healthcare systems and economies around the world The scale of production and accessible price of our products help to limit rising healthcare costs and improve patient health outcomes. We also invest hundreds of millions of pounds every year to enable our scientists to develop specialty and biopharmaceutical treatments that aim to improve patients’ health and increase access to medicines. 03 Delivering value to the NHS Like all health systems globally, the NHS is under intense financial pressure driven by growing patient demand from a population that is aging (who are often managing multiple chronic conditions) and by rising costs. We're working hard to help the NHS do more with less by delivering value through our generic medicines. They are typically sold at a substantially lower price compared to their branded medicine counterparts, as the development process is generally less costly. Generic medicines bring significant savings to the NHS medicines bill – estimates are that generic medicines save the NHS around £13 billion every year, in England and Wales, compared to the cost if their branded equivalents had been dispensed.02 This frees up valuable NHS resources to be directed to where patients need it most. As one of the leading generic medicines suppliers in the UK, Teva was responsible for £2.78 billion of these savings in 2020 - that’s the equivalent of more than 114,000 new nurses or just under 100,000 junior doctors.03 £ Billion 0 0 in England and Wales The chances are, someone you know is living a healthier life, because of our medicines - after all, we are one of the largest suppliers of prescription medicines to the NHS 04 05 1 in 5 generic medicine packs supplied to UK pharmacies is a Teva medicine 1 in 6 prescription medicine packs supplied to UK pharmacies is a Teva medicine 04 Proud to be positively impacting the UK’s Economy Teva is a major employer in the UK with over a thousand highly skilled colleagues working in our research, manufacturing and commercial operations As an employer and a manufacturer, Teva creates jobs and contributes to economic output. Beyond direct expenditures, Teva's spending initiates a series of income creation, spending and re-spending that support other jobs and contribute to additional Gross Domestic Product (GDP) and overall economic output. Teva’s economic impact in 2020 included supporting nearly 41,000 full-time jobs, contributing £10.1 billion to economic output and generating £2 billion in labour income, a measure of aggregate worker wages. 06 10 billion to economic output 2 billion in labour income 41,000 jobs supported Investing in the UK We have sites across the UK with extensive operations that span all aspects of bringing medicines to market. They are, all working together to provide high-quality medicines to millions of patients - not just in the UK, but worldwide. Research and Manufacturing Runcorn, Cheshire is home to our manufacturing facility for sterile liquid products, mainly used in the treatment of respiratory conditions, as well as multiple sclerosis and migraine, which are distributed to countries around the world. It’s also the base for two research and development centres developing sterile drug products and sterile device technology. Our Larne site in Northern Ireland is a research and development facility focusing on branded and generic developments in medical implants and devices. Commercial activities Our UK commercial headquarters and hi-tech logistics centre are based in Castleford, in the heart of the West Yorkshire. Our site in Harlow is home to many of our specialist teams, including Sales and Marketing, Medical, Regulatory Affairs and Legal. It’s a Centre of Excellence for Regulatory Affairs within Teva, with teams covering both European and global licensing for medicines and over-the-counter (OTC) products. Our field-based medical and commercial teams working with customers right across the UK. 05 Leveraging our global size and strength Teva is a big player on the world stage - that brings considerable benefits to patients in the UK We are continually expanding our range of medicines, devices and services to better meet the needs of UK patients and to offer increased choice to healthcare professionals. 65 production sites 85 billion tablets & capsules annually 25 R&D and clinical development sites We produce approximately 85 billion tablets and capsules a year through our 65 manufacturing facilities in more than 30 countries. 07 We have a strong pipeline of innovative medicines at various developmental stages and we are actively investigating novel uses for existing treatments. 06 Improving the lives of patients Right now all across the country… A doctor is writing a prescription for a Teva medicine, to improve their patient’s health outcome A pharmacist is reaching for a Teva product, secure in the knowledge that Teva medicines meet the highest standards for quality and safety A parent is trusting a Teva medicine to help a sick child get well 85 years 1,800 medicines 66 million people in the UK And that means all across the UK, people you probably know are living a healthier life because of our medicines. References Back to contents. Internal analyses conducted by Global Insights, Access & Technologies estimating number of Teva consumers. Ref 2.1 dated August 2016; Ref 2.2 dated April 2019 Back to contents. British Generics Manufacturers Association https://www.britishgenerics.co.uk/about-generics.html - Accessed August 2021 Back to contents. Teva UK - Data on file Back to contents. Teva UK - Data on file Back to contents. Teva UK - Data on file Back to contents. Teva Economic Impact Report - Matrix Global Advisors estimate of Teva’s Macroeconomic Impact in the UK in 2020 Back to contents. Teva Global Operations - Internal Data Source Our history We've been around longer than the NHS, and that's going back a long way! Learn more Fast track your career We can offer you the chance to make a real difference in people's lives and add value to your career Learn more Date of preparation: August 2021 COB-UK-NP-00064 Contacts Contact us Reporting side effects Teva worldwide Clinical trials Website Information Terms and conditions Privacy policy Pharmacovigilance privacy policy Accessibility About Latest news COVID 19 Modern Slavery Act Follow Teva Facebook Twitter Linkedin Linkedin Registered in England No. 302461. Registered office: Teva UK Limited, Whistler Drive, Castleford, WF10 5HX We would like to collect some of your data to enhance your browsing experience, analyse, and measure your engagement with our content. By clicking [Accept] you consent to this and to sharing this data with our partners, including to serve you more relevant ads on other websites. If you continue without accepting, this cannot take place or will be less accurate. You can change your mind at any time. To find out more about your rights, our practices, the data we collect and our partners, click here. Reject All Accept Your Choices